Precautionary CosmoFer® recall

October 22, 2008

Due to potential risk of particulate formation some CosmoFer® batches have been recalled as a precautionary measure. Read more about this at www.cosmofer.com

About Pharmacosmos A/S

Pharmacosmos develops and markets medicines for the treatment of iron deficiency. A research-based company, its ongoing R&D programme focuses on improving the treatment options for healthcare professionals, patients suffering from iron deficiency and veterinary treatments. .

Pharmacosmos is a family-owned Danish company and operates in more than 50 countries across Europe, the Americas and Asia. Its facilities are approved by both the Danish Medicines Agency and the US Food & Drug Administration.